Forbes November 13, 2024
Hera Biotech is developing a new diagnostic test for endometriosis that is more accurate and less invasive than current methods. The company was founded by Somer Baburek, a former venture capitalist, who saw a need for better diagnostic tools for this condition. Hera Biotech is currently seeking funding to finalize product development and launch its first diagnostic product to market.
Endometriosis: Hera Biotech Offers New Hope
Baburek, the visionary behind San Antonio, Texas-based Hera Biotech, has embarked on a mission to reshape the landscape of women’s health, particularly in endometriosis diagnosis and treatment. Her journey began in February 2020, fueled by a deep passion for women’s health, a personal connection to the challenges of endometriosis, and her career working in...
Today's Sponsors
Today's Sponsor